NVision
PrivateLast Round
Series B
May 13, 2026
Est. Valuation
$250M
Total Funding Raised
$151.3M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
NVision operates in Healthcare & Life Sciences and is based in Ulm. Its latest recorded funding round was a Series B round in May 2026.
NVision is a quantum technology company that develops quantum-based systems for healthcare, including quantum-enhanced MRI for metabolic imaging and quantum computing for drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Quantum Computing, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NVision Comparables
Compare NVision with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GE HealthCare Technologies Inc. | 78% | |
| XeUS Technologies Ltd | 78% | |
| Polarize ApS | 75% |
For institutional investors. Book with your work email.
NVision Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 13, 2026 | ||||
| Series B | May 13, 2026 | ||||
| Grant | Mar 16, 2026 | ||||
| Series A | Jun 22, 2023 | ||||
| Grant | Oct 12, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NVision Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund Denmark | Grant |
| European Commission | Seed |
| Entrée Capital | Series B, Series A |
| Playground Global | Series B, Seed, Series A |
| Kapitalbeteiligungsgesellschaft der Kreissparkasse Esslingen-Nürtingen mbH | Series A |
| European Investment Bank Group | Series B |
| Matterwave Ventures | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 13, 2026
$55M round led by Abbott Laboratories.
- May 13, 2026
$55M round led by Abbott Laboratories
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 28, 2026
Nvision Quantum announces plans to work with U.S.-based photonics company HyperLight on a chip platform incorporating films that contain molecular qubits and expects its first integrated chip prototypes in Q4 '26.
- receives_financingOct 28, 2026
Nvision Quantum has raised more than $155M in funding from firms such as Abbott Laboratories.
- launchesOct 28, 2026
Nvision Quantum unveils its first manufacturable molecular qubit in Germany on Oct 28th '26, with a peer-reviewed Nature paper validating an individually addressable organic molecular spin-photon interface for scalable quantum computing.
- integrates_withOct 28, 2026
On Oct 28th '26, Nvision Quantum plans to integrate thin-film molecular qubits with HyperLight Corporation's thin-film lithium niobate photonic technology to enable scalable quantum computing through photonic connections between and within processors, with initial integrated chip prototypes expected in Q4 '26.
- receives_financingOct 28, 2026
Nvision Quantum has raised $120M from public and private sources, including Abbott Laboratories.
For institutional investors. Book with your work email.
NVision Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NVision's valuation, stock price, and market status.
Is NVision a public or private company?
NVision is a private company.
What is the current stock price of NVision?
NVision is a private company, so its shares have no public market price. Caplight tracks NVision's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NVision worth (valuation)?
NVision's valuation is estimated at $250.0M based on funding round data.
Can I buy NVision stock?
NVision shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NVision's last funding round?
NVision's most recent funding round was Series B on May 13, 2026.
Who are the main investors in NVision?
Key investors in NVision include Playground Global.
Will NVision IPO soon?
No public IPO plans have been announced for NVision.
How can I track NVision secondary market activity?
Caplight tracks bids, offers, and trades in NVision's shares on secondary markets.